BACKGROUND: Human papillomavirus (HPV) DNA testing has been shown to be an effective approach to cervical cancer screening, and self-collection sampling for HPV testing could be a potential alternative to Pap test, provided that women who tested positive by any method get timely follow-up and care. This feasibility study examined acceptability and usability of self-collected sampling for HPV testing among African-American (AA) women in the Mississippi Delta to inform the development of interventions to promote cervical cancer screening in this population. METHODS: The study consisted of two phases. Phase I consisted of eight focus groups (n = 87) with AA women to explore knowledge, attitudes, and beliefs about cervical cancer and HPV infection as well as acceptability of self-collected sampling for HPV testing. In phase II, we examined the usability of this technology through one discussion group (n = 9). The Health Belief Model guided data collection and analysis. RESULTS: Although participants perceived themselves as susceptible to cervical cancer and acknowledged its severity, there was a lack of knowledge of the link between HPV and cervical cancer, and they expressed a number of misconceptions. The most frequent barriers to screening included embarrassment, discomfort, and fear of the results. Women in both phases were receptive to self-collected sampling for HPV testing. All participants in the usability phase expressed that self-collection was easy and they did not experience any difficulties. CONCLUSION: Self-collection for HPV testing is an acceptable and feasible method among AA women in the Mississippi Delta to complement current cytology cervical cancer screening programs.
BACKGROUND:Human papillomavirus (HPV) DNA testing has been shown to be an effective approach to cervical cancer screening, and self-collection sampling for HPV testing could be a potential alternative to Pap test, provided that women who tested positive by any method get timely follow-up and care. This feasibility study examined acceptability and usability of self-collected sampling for HPV testing among African-American (AA) women in the Mississippi Delta to inform the development of interventions to promote cervical cancer screening in this population. METHODS: The study consisted of two phases. Phase I consisted of eight focus groups (n = 87) with AA women to explore knowledge, attitudes, and beliefs about cervical cancer and HPV infection as well as acceptability of self-collected sampling for HPV testing. In phase II, we examined the usability of this technology through one discussion group (n = 9). The Health Belief Model guided data collection and analysis. RESULTS: Although participants perceived themselves as susceptible to cervical cancer and acknowledged its severity, there was a lack of knowledge of the link between HPV and cervical cancer, and they expressed a number of misconceptions. The most frequent barriers to screening included embarrassment, discomfort, and fear of the results. Women in both phases were receptive to self-collected sampling for HPV testing. All participants in the usability phase expressed that self-collection was easy and they did not experience any difficulties. CONCLUSION: Self-collection for HPV testing is an acceptable and feasible method among AA women in the Mississippi Delta to complement current cytology cervical cancer screening programs.
Authors: P E Gravitt; J V Lacey; L A Brinton; W A Barnes; J R Kornegay; M D Greenberg; S M Greene; O C Hadjimichael; L McGowan; R Mortel; P E Schwartz; R Zaino; A Hildesheim Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-02 Impact factor: 4.254
Authors: Melanie E Palmisano; Ann M Gaffga; Jennifer Daigle; Joeli Brinkman; Kristina Mire; Karen Lenczyk; David H Martin; Michael E Hagensee Journal: Int J STD AIDS Date: 2003-08 Impact factor: 1.359
Authors: J L Belinson; Y L Qiao; R G Pretorius; W H Zhang; S D Rong; M N Huang; F H Zhao; L Y Wu; S D Ren; R D Huang; M F Washington; Q J Pan; L Li; D Fife Journal: Int J Gynecol Cancer Date: 2003 Nov-Dec Impact factor: 3.437
Authors: Diane M Harper; Meghan R Longacre; Walter W Noll; Dorothy R Belloni; Bernard F Cole Journal: Ann Fam Med Date: 2003 Nov-Dec Impact factor: 5.166
Authors: Jessica A Kahn; Gail B Slap; Bin Huang; Susan L Rosenthal; Abbigail M Wanchick; Linda M Kollar; Paula A Hillard; David Witte; Pam Groen; David I Bernstein Journal: Obstet Gynecol Date: 2004-05 Impact factor: 7.661
Authors: Francisco Garcia; Bel Barker; Carlos Santos; Elena Mendez Brown; Thomas Nuño; Anna Giuliano; John Davis Journal: Obstet Gynecol Date: 2003-08 Impact factor: 7.661
Authors: Joakim Dillner; Matejka Rebolj; Philippe Birembaut; Karl-Ulrich Petry; Anne Szarewski; Christian Munk; Silvia de Sanjose; Pontus Naucler; Belen Lloveras; Susanne Kjaer; Jack Cuzick; Marjolein van Ballegooijen; Christine Clavel; Thomas Iftner Journal: BMJ Date: 2008-10-13
Authors: Anna Lucas-Wright; Mohsen Bazargan; Loretta Jones; Jaydutt V Vadgama; Roberto Vargas; Marianna Sarkissyan; James Smith; Hamed Yazdanshenas; Annette E Maxwell Journal: J Community Health Date: 2014-02
Authors: Andrea C Des Marais; Yuqian Zhao; Marcia M Hobbs; Vijay Sivaraman; Lynn Barclay; Noel T Brewer; Jennifer S Smith Journal: Obstet Gynecol Date: 2018-12 Impact factor: 7.661
Authors: Robin C Vanderpool; Maudella G Jones; Lindsay R Stradtman; Jennifer S Smith; Richard A Crosby Journal: Gynecol Oncol Date: 2013-10-11 Impact factor: 5.482
Authors: Erik J Nelson; John Hughes; J Michael Oakes; Bharat Thyagarajan; James S Pankow; Shalini L Kulasingam Journal: J Community Health Date: 2015-06
Authors: Kayoll V Galbraith; Melissa B Gilkey; Jennifer S Smith; Alice R Richman; Lynn Barclay; Noel T Brewer Journal: J Community Health Date: 2014-10
Authors: Paul L Reiter; Abigail B Shoben; Deborah McDonough; Mack T Ruffin; Martin Steinau; Elizabeth R Unger; Electra D Paskett; Mira L Katz Journal: Sex Transm Dis Date: 2019-03 Impact factor: 2.830
Authors: Chelsea Anderson; Lindsay Breithaupt; Andrea Des Marais; Charlotte Rastas; Alice Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith Journal: Sex Transm Infect Date: 2017-09-02 Impact factor: 3.519